{"id":{"repo_id":"cambridge","oai_identifier":"oai:www.repository.cam.ac.uk:1810/325041"},"canonical_url":"https://search.dev.ndltd.org/etd/cambridge/oai:www.repository.cam.ac.uk:1810/325041","repository":{"repo_id":"cambridge","name":"Cambridge University","base_url":"https://api.repository.cam.ac.uk/server/oai/request"},"display":{"title":"Strategy for Controlled Protection of Redox-Cycling Ortho-Quinones with Self-Immolative Linkers","abstract":"[Restricted]","abstract_html":"[Restricted]","abstract_has_math":false,"creators":["Dunsmore, Lavinia"],"institution":"University of Cambridge","degree_name":"Doctor of Philosophy (PhD)","degree_level":"Doctoral","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":["Bernardes, Gonçalo"],"committee_chairs":[],"committee_members":[],"year":2021,"date_issued":"2021-06-30","date_published":"2021-06-30","updated_at":"2026-07-22T22:24:17Z","subjects":["ortho-quinone","quinone","lapachone","beta-lapachone","prodrug","self-immolative linker","pH dependence","para-aminobenzyl ketol","para-hydroxybenzyl ketol","redox","redox cycling","antibody-drug conjugate","ADC","targeted therapy","acute myeloid leukaemia"],"languages":["eng"],"rights":[],"rights_urls":["https://apollo8-f-pro.lib.cam.ac.uk/bitstreams/1d576997-63e9-4234-b181-21c1b9831854/download","https://www.rioxx.net/licenses/all-rights-reserved/"],"identifier_entries":[{"key":"dc:creator.authoridentifier","label":"Author Identifier","values":["0000000291256081"],"render_values":[{"text":"0000-0002-9125-6081","href":"https://orcid.org/0000-0002-9125-6081","code":true}]}]},"links":{"outbound_url":"https://doi.org/10.17863/CAM.72496","outbound_label":"DOI","outbound_source":"dc:identifier.doi"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Bernardes, Gonçalo"]},{"key":"dc:contributor.sponsor","label":"Sponsor","values":["UKRI BBSRC DTP PhD Studentship (1795534)"]},{"key":"dc:creator","label":"Author","values":["Dunsmore, Lavinia"]},{"key":"dc:creator.authoridentifier","label":"Author Identifier","values":["0000000291256081"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.issued","label":"Date","values":["2021-06-30"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Cambridge"]},{"key":"dc:relation.isreferencedby.uri","label":"Dc Relation Isreferencedby URI","values":["https://www.repository.cam.ac.uk/handle/1810/325041"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["Doctoral"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["Doctor of Philosophy (PhD)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["ortho-quinone","quinone","lapachone","beta-lapachone","prodrug","self-immolative linker","pH dependence","para-aminobenzyl ketol","para-hydroxybenzyl ketol","redox","redox cycling","antibody-drug conjugate","ADC","targeted therapy","acute myeloid leukaemia"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["https://apollo8-f-pro.lib.cam.ac.uk/bitstreams/1d576997-63e9-4234-b181-21c1b9831854/download","https://www.rioxx.net/licenses/all-rights-reserved/"]},{"key":"dc:rights.embargotype","label":"Dc Rights Embargotype","values":["restricted"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.doi","label":"DOI","values":["10.17863/CAM.72496"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["[Restricted]"]},{"key":"dc:format.checksum.md5","label":"Dc Format Checksum Md5","values":["353adac0d1ebdfd65ab16480263c3c87"]},{"key":"dc:title","label":"Title","values":["Strategy for Controlled Protection of Redox-Cycling Ortho-Quinones with Self-Immolative Linkers"]}]}],"canonical_facts":{"dc:contributor.advisor":["Bernardes, Gonçalo"],"dc:contributor.sponsor":["UKRI BBSRC DTP PhD Studentship (1795534)"],"dc:creator":["Dunsmore, Lavinia"],"dc:creator.authoridentifier":["0000000291256081"],"dc:date.issued":["2021-06-30"],"dc:description.abstract":["[Restricted]"],"dc:format.checksum.md5":["353adac0d1ebdfd65ab16480263c3c87"],"dc:identifier.doi":["10.17863/CAM.72496"],"dc:language":["eng"],"dc:publisher.institution":["University of Cambridge"],"dc:relation.isreferencedby.uri":["https://www.repository.cam.ac.uk/handle/1810/325041"],"dc:rights":["https://apollo8-f-pro.lib.cam.ac.uk/bitstreams/1d576997-63e9-4234-b181-21c1b9831854/download","https://www.rioxx.net/licenses/all-rights-reserved/"],"dc:rights.embargotype":["restricted"],"dc:subject":["ortho-quinone","quinone","lapachone","beta-lapachone","prodrug","self-immolative linker","pH dependence","para-aminobenzyl ketol","para-hydroxybenzyl ketol","redox","redox cycling","antibody-drug conjugate","ADC","targeted therapy","acute myeloid leukaemia"],"dc:title":["Strategy for Controlled Protection of Redox-Cycling Ortho-Quinones with Self-Immolative Linkers"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["Doctoral"],"dc:type.qualificationname":["Doctor of Philosophy (PhD)"]},"updated_at":"2026-07-22T22:24:17Z"}